Situacion de La Industria Farmaceutica en El Perú

 

QKXUCAKLD HE NC KDHUQXZKC ICZGCAEUXKAC ED EN REZÐ

Nc kdhustrkc icrgcaëuac es ud kdmresl ancve ed nc ealdlgçc hen pcçs, yc que dl es slnl gldetcrkl, sk dl tcgjkëd, aldtrkjuye c nc scnuh he nc pljncakñd, kduyedhl ed tlhls nls ltrls seatlres. Ed en cól :239 ncs vedtcs he nc kdhustrkc icrgcaëuac kdaregedtl he UQ$ 3,562 gknnldes c UQ$ 3,=82 gknnldes ed en cól :23=? nl que represedtñ ud areakgkedtl he 32.3%. Hurcdte en :236, ncs vedtcs tuvkerld ud areakgkedtl he 9.:%, ald ud gldtl cnrehehlr he UQ$ 3,652 gknnldes. Rcrc :23; ncs vedtcs akerrcd ald ud esgchl he UQ$ 3,;:2 gknnldes, ald ud neve areakgkedtl ald respeatl cn cól cdterklr hen =.2%.

Areakgkedtl Areakgke dtl Kdhustrkc Icrgcaeuac I crgcaeuac :2:2 :23; :236 :23= :239 :235 :238 $3,562

$3,=82

$3,652

$3,;:2

$ Gknnldes

  Iuedte0 Encjlrcakñd prlpkc Ed nc catucnkhch, nc kdhustrkc icrgcaëuac dl fc skhl kdgude c nc hksgkduakld he areakgkedtl hejkhl c nc pcdhegkc plr Alvkh-3;, se espercjc que nc kdhustrkc cugedtcrc, perl dl iue csç, cudque fujl gcs hegcdhc he gehkacgedtls, dl se ljtuvl en areakgkedtl que se espercjc, Ed  `udkl :2:2 en areakgkedtl iue he 2%, estl puehe ser c acusc he que en estchl estc algprcdhl hkreatcgedte cn extrcd`erl y dl c nc kdhustrkc dcakldcn. En preskhedte hen mregkl, @lsë Edrkque Qknvc, kdhkañ que nls prlhuatls icrgcaëuals represedtcjcd en 2.:5% he nc estruaturc prlhuavc hen pcçs ed en cól :22= y se rehu`l c 2.31% cn akerre hen cól :2:2, cól he nc pcdhegkc hen ALYKH-3;.

Aldanuskldes0

Qe esperc que nc kdhustrkc icrgcaëuac remrese plal c plal c nc tedhedakc que tedkc he areakgkedtl pcuncdcgedte udc vez se aldtrlne nc pcdhegkc, es udc kdhustrkc redtcjne, perl ald akertls cspeatls que ge`lrcr, edtre ennls e nnls nc allrhkdcakñd he ncs persldcs kdvlnuarchcs, acpcakhch he prlhuaakñd pcrc ctedher tlhl pl he hegcdhcs y dl acer ed hëakt, udc ge`lr nemksncakñd que rk`c este seatlr y se glnhee c nls pcrãgetrls deaescrkls.

En estchl heje trcjc`cr ed udc ge`lr cskmdcakñd he nls reaursls he nc scnuh, skedhl ud tegc he cntc kgplrtcdakc, dl se puehe acer ed nc heslrmcdkzcakñd l icntc he ennc e nnc pcrc ediredtcr y reslnver nls prljnegcs he scnuh ed nc pljncakñd.

 

Ikmurc 30 Dltc he predsc hen hkcrkl Alrrel, Mregkl Icrgcaëual CHKICD seócnc se ócnc alrrupakñd ed

kdhustrkc plr algprc he gehkacgedtls cn extrcd`erl.

Jkjnklmrcc0 Lgdkc (:5 cmlstl, :2:2), Kdhustrkc icrgcaëuac perucdc recnkzñ cvcdaes skmdkacvls, Lgdkc Qlnutld, fps0//www.lgdkcslnuld.alg/jnlm/kdhustrkc-icrgcaeuac-perucdc-recnkzl-cvcdaesskmdkacvls/

Zehcaakld mesñd ( 3; he gcrzl, :2:3), Kdhustrkc icrgcaëuac perucdc he`c he prlhuakr UQ$ :=2 gknnldes plr icntc he plnçacs, Mestld, fps0//mesld.pe/ealdlgkc/kdhustrkc-icrgcaeuacperucdc-he`c-he-prlhuakr-us-:=2-gknnldes-plr-icntc-he-plnkacs-dlakc/